Get started
Author

Akhila Kavirayani

Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guideline
2023 · Miriam F Cox, Strachan Mackenzie, et al. · The Lancet Rheumatology · 62
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project
2024 · Francesco Baldo, Remco G A Erkens, et al. · Rheumatology · 53
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
2023 · Samuel Channon-Wells, Ortensia Vito, et al. · The Lancet Rheumatology · 51
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
2019 · A. V. Ramanan, L. V. Hampson, et al. · PLoS ONE · 36
PDF
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review
2023 · James E. G. Charlesworth, Akhila Kavirayani · European Journal Of Haematology · 28
PDF
Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
2019 · Noémi B A Roy, Ahmad I Zaal, et al. · Rheumatology · 27
Paediatric rheumatology practice in the UK benchmarked against the British Society for Paediatric and Adolescent Rheumatology/Arthritis and Musculoskeletal Alliance Standards of Care for juvenile idiopathic arthritis
2013 · Akhila Kavirayani, Helen E. Foster · Rheumatology · 23
Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children
2021 · James E.G. Charlesworth, Shaun Wilson, et al. · Pediatric Blood & Cancer · 22
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs
2025 · Katie Bechman, Kaiyang Song, et al. · Rheumatology · 16
PDF
The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLH
2020 · Akhila Kavirayani, James E G Charlesworth, et al. · The Lancet Rheumatology · 16
PDF
Physical and social functioning in adolescents with rheumatological conditions: a study of predictors
2012 · Jeremy Gauntlett‐Gilbert, Akhila Kavirayani, et al. · Acta Paediatrica · 13
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope
2024 · Louise Mercer, Abhishek Abhishek, et al. · Rheumatology Advances in Practice · 4
PDF
Vitamin D may influence disease course in PIMS ‐ TS / MIS ‐C: An observational cohort study
2025 · James E. G. Charlesworth, Joshua Navarajasegaran, et al. · Pediatrics International · 2
PDF
Pediatric rheumatology: An under-recognized subspecialty in India
2017 · Akhila Kavirayani, Suma Balan · International Journal of Advanced Medical and Health Research · 2
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope
2025 · Stephanie F Ling, Joshua L Bennett, et al. · Rheumatology Advances in Practice · 1
P27 Life-threatening macrophage activation syndrome with neurological involvement responding to very high dose IV anakinra
2018 · Akhila Kavirayani, Robin Basu-Roy, et al. · Rheumatology · 1
25. Kikuchi disease with extranodal involvement: response to IVIG and role of inflammatory markers
2017 · Akhila Kavirayani · Rheumatology · 1
BSPAR ANNUAL CONFERENCE ABSTRACTS * Oral presentations * O1. The impact of modern management on outcomes of JIA compared with healthy controls
2012 · D. Lim, M. Todd, et al. · Rheumatology · 1
Double Trouble: Stroke in a Child with Down's Syndrome
2022 · Jacob Reading, Ree'Thee Bhatt, et al. · Journal of Pediatric Neurology
P35 Efficacy and tolerability of leflunomide as a DMARD in JIA: a single centre retrospective cohort study of 124 patients
2018 · Jessica L Gunn, Ahmad Zaal, et al. · Rheumatology
Preparing Manuscript from Thesis Material and Selecting Journals for Submission
2018 · Vikram Kate, Sathasivam Sureshkumar, et al. · Springer eBooks
72. Lyme arthritis: Antirheumatic therapy or antibiotics?
2017 · Akhila Kavirayani, Surjo De, et al. · Rheumatology
023. Autoinflammatory bone disease: Majeed syndrome- description of a novel mutation and therapeutic response to Bisphosphonates and IL-1 blockade
2017 · Akhila Kavirayani, Sarah Sacks, et al. · Rheumatology
029. Kikuchi disease as a heralding feature of Undifferentiated Connective Tissue Disease (MCTD predominant)
2017 · Akhila Kavirayani, Sarah Sacks, et al. · Rheumatology
040. Leflunomide as a DMARD in JIA: efficacy and tolerability based on a minimum of three year follow up data
2017 · Sarah Sacks, Ruth Finch, et al. · Rheumatology
Works count: 31
Citation count: 361
H-index: 11
I10-index: 11
Year
Topic
Type